 | • レポートコード：QY2112C03918 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はプロプラノロール薬の世界市場の現状について調査・分析し、2027年までの市場を予測しました。プロプラノロール薬の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（経口、注射）、用途別市場規模（不整脈、高血圧、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・プロプラノロール薬の世界市場概要 ・メーカー別の競争状況、市場シェア ・プロプラノロール薬の種類別市場規模：経口、注射 ・プロプラノロール薬の用途別市場規模：不整脈、高血圧、その他 ・北米のプロプラノロール薬市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのプロプラノロール薬市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのプロプラノロール薬市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のプロプラノロール薬市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのプロプラノロール薬市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Apotex、Teva、Atnahs Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentiva ・プロプラノロール薬のバリューチェーン・販売チャネル分析 ・プロプラノロール薬の世界市場動向 |
Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Market Analysis and Insights: Global Propranolol Drug Market
The global Propranolol Drug market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Propranolol Drug Scope and Segment
Propranolol Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Propranolol Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Arrhythmia
Hypertension
Other
By Company
Apotex
Teva
Atnahs Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Propranolol Drug Product Introduction
1.2 Market by Type
1.2.1 Global Propranolol Drug Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Propranolol Drug Market Size Growth Rate by Application
1.3.2 Arrhythmia
1.3.3 Hypertension
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Propranolol Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Propranolol Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Propranolol Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Propranolol Drug Regions by Sales
2.4.1 Global Top Propranolol Drug Regions by Sales (2016-2021)
2.4.2 Global Top Propranolol Drug Regions by Sales (2022-2027)
2.5 Global Top Propranolol Drug Regions by Revenue
2.5.1 Global Top Propranolol Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Propranolol Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Propranolol Drug Sales by Manufacturers
3.1.1 Global Top Propranolol Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Propranolol Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Propranolol Drug Sales in 2020
3.2 Global Propranolol Drug Revenue by Manufacturers
3.2.1 Global Top Propranolol Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Propranolol Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Propranolol Drug Revenue in 2020
3.3 Global Propranolol Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Propranolol Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Propranolol Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Propranolol Drug Sales by Type
4.1.1 Global Propranolol Drug Historical Sales by Type (2016-2021)
4.1.2 Global Propranolol Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Propranolol Drug Sales Market Share by Type (2016-2027)
4.2 Global Propranolol Drug Revenue by Type
4.2.1 Global Propranolol Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Propranolol Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Propranolol Drug Revenue Market Share by Type (2016-2027)
4.3 Global Propranolol Drug Price by Type
4.3.1 Global Propranolol Drug Price by Type (2016-2021)
4.3.2 Global Propranolol Drug Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Propranolol Drug Sales by Application
5.1.1 Global Propranolol Drug Historical Sales by Application (2016-2021)
5.1.2 Global Propranolol Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Propranolol Drug Sales Market Share by Application (2016-2027)
5.2 Global Propranolol Drug Revenue by Application
5.2.1 Global Propranolol Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Propranolol Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Propranolol Drug Revenue Market Share by Application (2016-2027)
5.3 Global Propranolol Drug Price by Application
5.3.1 Global Propranolol Drug Price by Application (2016-2021)
5.3.2 Global Propranolol Drug Price Forecast by Application (2022-2027)
6 North America
6.1 North America Propranolol Drug Market Size by Type
6.1.1 North America Propranolol Drug Sales by Type (2016-2027)
6.1.2 North America Propranolol Drug Revenue by Type (2016-2027)
6.2 North America Propranolol Drug Market Size by Application
6.2.1 North America Propranolol Drug Sales by Application (2016-2027)
6.2.2 North America Propranolol Drug Revenue by Application (2016-2027)
6.3 North America Propranolol Drug Market Size by Country
6.3.1 North America Propranolol Drug Sales by Country (2016-2027)
6.3.2 North America Propranolol Drug Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Propranolol Drug Market Size by Type
7.1.1 Europe Propranolol Drug Sales by Type (2016-2027)
7.1.2 Europe Propranolol Drug Revenue by Type (2016-2027)
7.2 Europe Propranolol Drug Market Size by Application
7.2.1 Europe Propranolol Drug Sales by Application (2016-2027)
7.2.2 Europe Propranolol Drug Revenue by Application (2016-2027)
7.3 Europe Propranolol Drug Market Size by Country
7.3.1 Europe Propranolol Drug Sales by Country (2016-2027)
7.3.2 Europe Propranolol Drug Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Propranolol Drug Market Size by Type
8.1.1 Asia Pacific Propranolol Drug Sales by Type (2016-2027)
8.1.2 Asia Pacific Propranolol Drug Revenue by Type (2016-2027)
8.2 Asia Pacific Propranolol Drug Market Size by Application
8.2.1 Asia Pacific Propranolol Drug Sales by Application (2016-2027)
8.2.2 Asia Pacific Propranolol Drug Revenue by Application (2016-2027)
8.3 Asia Pacific Propranolol Drug Market Size by Region
8.3.1 Asia Pacific Propranolol Drug Sales by Region (2016-2027)
8.3.2 Asia Pacific Propranolol Drug Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Propranolol Drug Market Size by Type
9.1.1 Latin America Propranolol Drug Sales by Type (2016-2027)
9.1.2 Latin America Propranolol Drug Revenue by Type (2016-2027)
9.2 Latin America Propranolol Drug Market Size by Application
9.2.1 Latin America Propranolol Drug Sales by Application (2016-2027)
9.2.2 Latin America Propranolol Drug Revenue by Application (2016-2027)
9.3 Latin America Propranolol Drug Market Size by Country
9.3.1 Latin America Propranolol Drug Sales by Country (2016-2027)
9.3.2 Latin America Propranolol Drug Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Propranolol Drug Market Size by Type
10.1.1 Middle East and Africa Propranolol Drug Sales by Type (2016-2027)
10.1.2 Middle East and Africa Propranolol Drug Revenue by Type (2016-2027)
10.2 Middle East and Africa Propranolol Drug Market Size by Application
10.2.1 Middle East and Africa Propranolol Drug Sales by Application (2016-2027)
10.2.2 Middle East and Africa Propranolol Drug Revenue by Application (2016-2027)
10.3 Middle East and Africa Propranolol Drug Market Size by Country
10.3.1 Middle East and Africa Propranolol Drug Sales by Country (2016-2027)
10.3.2 Middle East and Africa Propranolol Drug Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Apotex
11.1.1 Apotex Corporation Information
11.1.2 Apotex Overview
11.1.3 Apotex Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Apotex Propranolol Drug Product Description
11.1.5 Apotex Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Teva Propranolol Drug Product Description
11.2.5 Teva Recent Developments
11.3 Atnahs Pharma
11.3.1 Atnahs Pharma Corporation Information
11.3.2 Atnahs Pharma Overview
11.3.3 Atnahs Pharma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Atnahs Pharma Propranolol Drug Product Description
11.3.5 Atnahs Pharma Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 AstraZeneca Propranolol Drug Product Description
11.4.5 AstraZeneca Recent Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mylan Propranolol Drug Product Description
11.5.5 Mylan Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Novartis Propranolol Drug Product Description
11.6.5 Novartis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Sanofi Propranolol Drug Product Description
11.7.5 Sanofi Recent Developments
11.8 Yabang Pharma
11.8.1 Yabang Pharma Corporation Information
11.8.2 Yabang Pharma Overview
11.8.3 Yabang Pharma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Yabang Pharma Propranolol Drug Product Description
11.8.5 Yabang Pharma Recent Developments
11.9 Sawai Seiyaku
11.9.1 Sawai Seiyaku Corporation Information
11.9.2 Sawai Seiyaku Overview
11.9.3 Sawai Seiyaku Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Sawai Seiyaku Propranolol Drug Product Description
11.9.5 Sawai Seiyaku Recent Developments
11.10 ABZ-Pharma
11.10.1 ABZ-Pharma Corporation Information
11.10.2 ABZ-Pharma Overview
11.10.3 ABZ-Pharma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 ABZ-Pharma Propranolol Drug Product Description
11.10.5 ABZ-Pharma Recent Developments
11.11 Towa Yakuhin
11.11.1 Towa Yakuhin Corporation Information
11.11.2 Towa Yakuhin Overview
11.11.3 Towa Yakuhin Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Towa Yakuhin Propranolol Drug Product Description
11.11.5 Towa Yakuhin Recent Developments
11.12 Zydus Pharma
11.12.1 Zydus Pharma Corporation Information
11.12.2 Zydus Pharma Overview
11.12.3 Zydus Pharma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Zydus Pharma Propranolol Drug Product Description
11.12.5 Zydus Pharma Recent Developments
11.13 Nichi-Iko Pharmaceutical
11.13.1 Nichi-Iko Pharmaceutical Corporation Information
11.13.2 Nichi-Iko Pharmaceutical Overview
11.13.3 Nichi-Iko Pharmaceutical Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Nichi-Iko Pharmaceutical Propranolol Drug Product Description
11.13.5 Nichi-Iko Pharmaceutical Recent Developments
11.14 Intas Pharma
11.14.1 Intas Pharma Corporation Information
11.14.2 Intas Pharma Overview
11.14.3 Intas Pharma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Intas Pharma Propranolol Drug Product Description
11.14.5 Intas Pharma Recent Developments
11.15 IFET
11.15.1 IFET Corporation Information
11.15.2 IFET Overview
11.15.3 IFET Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 IFET Propranolol Drug Product Description
11.15.5 IFET Recent Developments
11.16 Iqfarma
11.16.1 Iqfarma Corporation Information
11.16.2 Iqfarma Overview
11.16.3 Iqfarma Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Iqfarma Propranolol Drug Product Description
11.16.5 Iqfarma Recent Developments
11.17 Zentiva
11.17.1 Zentiva Corporation Information
11.17.2 Zentiva Overview
11.17.3 Zentiva Propranolol Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Zentiva Propranolol Drug Product Description
11.17.5 Zentiva Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Propranolol Drug Value Chain Analysis
12.2 Propranolol Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Propranolol Drug Production Mode & Process
12.4 Propranolol Drug Sales and Marketing
12.4.1 Propranolol Drug Sales Channels
12.4.2 Propranolol Drug Distributors
12.5 Propranolol Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Propranolol Drug Industry Trends
13.2 Propranolol Drug Market Drivers
13.3 Propranolol Drug Market Challenges
13.4 Propranolol Drug Market Restraints
14 Key Findings in The Global Propranolol Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Propranolol Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injection
Table 4. Global Propranolol Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Propranolol Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Propranolol Drug Sales by Region (2016-2021) & (K Units)
Table 7. Global Propranolol Drug Sales Market Share by Region (2016-2021)
Table 8. Global Propranolol Drug Sales by Region (2022-2027) & (K Units)
Table 9. Global Propranolol Drug Sales Market Share by Region (2022-2027)
Table 10. Global Propranolol Drug Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Propranolol Drug Revenue Market Share by Region (2016-2021)
Table 12. Global Propranolol Drug Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Propranolol Drug Revenue Market Share by Region (2022-2027)
Table 14. Global Propranolol Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Propranolol Drug Sales Share by Manufacturers (2016-2021)
Table 16. Global Propranolol Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Propranolol Drug Revenue Share by Manufacturers (2016-2021)
Table 18. Propranolol Drug Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Propranolol Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Propranolol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propranolol Drug as of 2020)
Table 21. Propranolol Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Propranolol Drug Product Offered
Table 23. Date of Manufacturers Enter into Propranolol Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 26. Global Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 27. Global Propranolol Drug Sales Share by Type (2016-2021)
Table 28. Global Propranolol Drug Sales Share by Type (2022-2027)
Table 29. Global Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Propranolol Drug Revenue Share by Type (2016-2021)
Table 32. Global Propranolol Drug Revenue Share by Type (2022-2027)
Table 33. Propranolol Drug Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Propranolol Drug Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 36. Global Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 37. Global Propranolol Drug Sales Share by Application (2016-2021)
Table 38. Global Propranolol Drug Sales Share by Application (2022-2027)
Table 39. Global Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Propranolol Drug Revenue Share by Application (2016-2021)
Table 42. Global Propranolol Drug Revenue Share by Application (2022-2027)
Table 43. Propranolol Drug Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Propranolol Drug Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 46. North America Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 47. North America Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 50. North America Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 51. North America Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Propranolol Drug Sales by Country (2016-2021) & (K Units)
Table 54. North America Propranolol Drug Sales by Country (2022-2027) & (K Units)
Table 55. North America Propranolol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Propranolol Drug Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 58. Europe Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 59. Europe Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 62. Europe Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 63. Europe Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Propranolol Drug Sales by Country (2016-2021) & (K Units)
Table 66. Europe Propranolol Drug Sales by Country (2022-2027) & (K Units)
Table 67. Europe Propranolol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Propranolol Drug Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Propranolol Drug Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Propranolol Drug Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Propranolol Drug Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Propranolol Drug Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Propranolol Drug Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Propranolol Drug Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Propranolol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Propranolol Drug Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Propranolol Drug Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Propranolol Drug Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Propranolol Drug Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Propranolol Drug Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Propranolol Drug Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Propranolol Drug Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Propranolol Drug Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Propranolol Drug Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Propranolol Drug Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Propranolol Drug Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Propranolol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Propranolol Drug Revenue by Country (2022-2027) & (US$ Million)
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Major Businesses
Table 107. Apotex Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Apotex Propranolol Drug Product
Table 109. Apotex Recent Developments
Table 110. Teva Corporation Information
Table 111. Teva Description and Major Businesses
Table 112. Teva Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Teva Propranolol Drug Product
Table 114. Teva Recent Developments
Table 115. Atnahs Pharma Corporation Information
Table 116. Atnahs Pharma Description and Major Businesses
Table 117. Atnahs Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Atnahs Pharma Propranolol Drug Product
Table 119. Atnahs Pharma Recent Developments
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Major Businesses
Table 122. AstraZeneca Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. AstraZeneca Propranolol Drug Product
Table 124. AstraZeneca Recent Developments
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Major Businesses
Table 127. Mylan Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Mylan Propranolol Drug Product
Table 129. Mylan Recent Developments
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Major Businesses
Table 132. Novartis Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Novartis Propranolol Drug Product
Table 134. Novartis Recent Developments
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Major Businesses
Table 137. Sanofi Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Sanofi Propranolol Drug Product
Table 139. Sanofi Recent Developments
Table 140. Yabang Pharma Corporation Information
Table 141. Yabang Pharma Description and Major Businesses
Table 142. Yabang Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Yabang Pharma Propranolol Drug Product
Table 144. Yabang Pharma Recent Developments
Table 145. Sawai Seiyaku Corporation Information
Table 146. Sawai Seiyaku Description and Major Businesses
Table 147. Sawai Seiyaku Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Sawai Seiyaku Propranolol Drug Product
Table 149. Sawai Seiyaku Recent Developments
Table 150. ABZ-Pharma Corporation Information
Table 151. ABZ-Pharma Description and Major Businesses
Table 152. ABZ-Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. ABZ-Pharma Propranolol Drug Product
Table 154. ABZ-Pharma Recent Developments
Table 155. Towa Yakuhin Corporation Information
Table 156. Towa Yakuhin Description and Major Businesses
Table 157. Towa Yakuhin Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Towa Yakuhin Propranolol Drug Product
Table 159. Towa Yakuhin Recent Developments
Table 160. Zydus Pharma Corporation Information
Table 161. Zydus Pharma Description and Major Businesses
Table 162. Zydus Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Zydus Pharma Propranolol Drug Product
Table 164. Zydus Pharma Recent Developments
Table 165. Nichi-Iko Pharmaceutical Corporation Information
Table 166. Nichi-Iko Pharmaceutical Description and Major Businesses
Table 167. Nichi-Iko Pharmaceutical Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Nichi-Iko Pharmaceutical Propranolol Drug Product
Table 169. Nichi-Iko Pharmaceutical Recent Developments
Table 170. Intas Pharma Corporation Information
Table 171. Intas Pharma Description and Major Businesses
Table 172. Intas Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Intas Pharma Propranolol Drug Product
Table 174. Intas Pharma Recent Developments
Table 175. IFET Corporation Information
Table 176. IFET Description and Major Businesses
Table 177. IFET Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. IFET Propranolol Drug Product
Table 179. IFET Recent Developments
Table 180. Iqfarma Corporation Information
Table 181. Iqfarma Description and Major Businesses
Table 182. Iqfarma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. Iqfarma Propranolol Drug Product
Table 184. Iqfarma Recent Developments
Table 185. Zentiva Corporation Information
Table 186. Zentiva Description and Major Businesses
Table 187. Zentiva Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 188. Zentiva Propranolol Drug Product
Table 189. Zentiva Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Propranolol Drug Distributors List
Table 193. Propranolol Drug Customers List
Table 194. Propranolol Drug Market Trends
Table 195. Propranolol Drug Market Drivers
Table 196. Propranolol Drug Market Challenges
Table 197. Propranolol Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Propranolol Drug Product Picture
Figure 2. Global Propranolol Drug Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Propranolol Drug Market Share by Application in 2020 & 2027
Figure 6. Arrhythmia
Figure 7. Hypertension
Figure 8. Other
Figure 9. Propranolol Drug Report Years Considered
Figure 10. Global Propranolol Drug Sales 2016-2027 (K Units)
Figure 11. Global Propranolol Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Propranolol Drug Revenue 2016-2027 (US$ Million)
Figure 13. Global Propranolol Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Propranolol Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Propranolol Drug Sales Market Share by Region (2022-2027)
Figure 16. North America Propranolol Drug Sales YoY (2016-2027) & (K Units)
Figure 17. North America Propranolol Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Propranolol Drug Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Propranolol Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Propranolol Drug Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Propranolol Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Propranolol Drug Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Propranolol Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Propranolol Drug Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Propranolol Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Propranolol Drug Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Propranolol Drug Revenue in 2020
Figure 28. Propranolol Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 30. Global Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 31. Global Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 32. Global Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 33. North America Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 34. North America Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 35. North America Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 36. North America Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 37. North America Propranolol Drug Sales Share by Country (2016-2027)
Figure 38. North America Propranolol Drug Revenue Share by Country (2016-2027)
Figure 39. United States Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 42. Europe Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 43. Europe Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 44. Europe Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 45. Europe Propranolol Drug Sales Share by Country (2016-2027)
Figure 46. Europe Propranolol Drug Revenue Share by Country (2016-2027)
Figure 47. Germany Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 48. France Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Propranolol Drug Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Propranolol Drug Revenue Share by Region (2016-2027)
Figure 58. China Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 61. India Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 68. Latin America Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 70. Latin America Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Propranolol Drug Sales Share by Country (2016-2027)
Figure 72. Latin America Propranolol Drug Revenue Share by Country (2016-2027)
Figure 73. Mexico Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Propranolol Drug Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Propranolol Drug Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Propranolol Drug Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Propranolol Drug Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Propranolol Drug Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Propranolol Drug Revenue Share by Country (2016-2027)
Figure 82. Turkey Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Propranolol Drug Revenue (2016-2027) & (US$ Million)
Figure 85. Propranolol Drug Value Chain
Figure 86. Propranolol Drug Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
ニタゾキサニド薬品のグローバル市場インサイト・予測（～2027年） Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Market Analysis and Insights: Global Nitazoxanide Drug Market The globa…- パラセタモール薬のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Paracetamol Drug Market The global Paracetamol Drug market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Paracetamol Drug Scope and Segment Paracetamol Drug mar…
- ミカファンギン薬剤のグローバル市場インサイト・予測（～2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. Market Analysis and Insights: Global Micafungin Drug Market The global Micafungin Drug market is valued at US$ million …
- ミカファンギンナトリウム薬剤のグローバル市場インサイト・予測（～2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. Market Analysis and Insights: Global Micafungin Sodium Drug Market The global Micafungin Sodium Drug market is valued a…
- 注射薬包装のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Injectable Drug Packaging Market The global Injectable Drug Packaging market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Injectable Drug Packaging Scope and Segment I…